Zobrazeno 1 - 5
of 5
pro vyhledávání: '"JM Giraldez-Montero"'
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Cow’s milk protein allergy (CMPA) is universally the most common food allergy in the first years of life, and the incidence has increased over the past few years. The presence of CMPA has important repercussions for patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::270a86be2a94bec7966dd79cada6cf43
https://doi.org/10.1136/ejhpharm-2020-eahpconf.106
https://doi.org/10.1136/ejhpharm-2020-eahpconf.106
Autor:
A Bayón Fernández, M Gonzalez Barcia, A Castro Balado, I Varela Rey, A Fernandez Ferreiro, I Zarra Ferro, I Adán Barrientos, JM Giraldez Montero
Publikováno v:
Section 3: Production and Compounding.
Background Defects in the urea cycle are genetic diseases in which nitrogen accumulates as ammonia, resulting as highly toxic, especially in paediatric patients. Sodium benzoate (SB) is conjugated with glycine, giving rise to hippurate, which is excr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26d67f035fd7d25d3876ad7f54ceec39
https://doi.org/10.1136/ejhpharm-2019-eahpconf.86
https://doi.org/10.1136/ejhpharm-2019-eahpconf.86
Autor:
A Fernández-Ferreiro, L García-Quintanilla, JM Giraldez-Montero, MJ Lamas, M Gonzalez-Barcia, S Blanco-Dorado
Publikováno v:
Eur J Hosp Pharm
BACKGROUND: Parenteral nutrition (PN) is a high-risk medication. For this reason quality control must be guaranteed. PURPOSE: To evaluate the impact of implementing an automated system (Exacta-Mix 2400(®) Baxa) on the quality of the elaboration of P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f39c6ade18bce15cddae3ae36a187a8d
https://europepmc.org/articles/PMC7535402/
https://europepmc.org/articles/PMC7535402/
Autor:
Rodríguez-Pombo L; Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma (GI-1645), Facultad de Farmacia, Materials Institute iMATUS and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain., de Castro-López MJ; Servicio de Neonatología, Unidad de Diagnóstico y Tratamiento de Enfermedades Metabólicas Congénitas, Health Research Institute of Santiago de Compostela (IDIS), Hospital Clínico Universitario de Santiago de Compostela, Universidad de Santiago de Compostela, IDIS, RICORS, CIBERER, MetabERN, Spain., Sánchez-Pintos P; Servicio de Neonatología, Unidad de Diagnóstico y Tratamiento de Enfermedades Metabólicas Congénitas, Health Research Institute of Santiago de Compostela (IDIS), Hospital Clínico Universitario de Santiago de Compostela, Universidad de Santiago de Compostela, IDIS, RICORS, CIBERER, MetabERN, Spain., Giraldez-Montero JM; Pharmacy Department, Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Travesía Choupana s/n, Santiago de Compostela 15706, Spain., Januskaite P; Department of Pharmaceutics, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK., Duran-Piñeiro G; Pharmacy Department, Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Travesía Choupana s/n, Santiago de Compostela 15706, Spain., Dolores Bóveda M; Servicio de Neonatología, Unidad de Diagnóstico y Tratamiento de Enfermedades Metabólicas Congénitas, Health Research Institute of Santiago de Compostela (IDIS), Hospital Clínico Universitario de Santiago de Compostela, Universidad de Santiago de Compostela, IDIS, RICORS, CIBERER, MetabERN, Spain., Alvarez-Lorenzo C; Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma (GI-1645), Facultad de Farmacia, Materials Institute iMATUS and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain., Basit AW; Department of Pharmaceutics, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK; FABRX Ltd., Henwood House, Henwood, Ashford, Kent TN24 8DH, UK; FABRX Artificial Intelligence, Carretera de Escairón, 14, Currelos (O Saviñao), CP 27543, Spain., Goyanes A; Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma (GI-1645), Facultad de Farmacia, Materials Institute iMATUS and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain; Department of Pharmaceutics, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK; FABRX Ltd., Henwood House, Henwood, Ashford, Kent TN24 8DH, UK; FABRX Artificial Intelligence, Carretera de Escairón, 14, Currelos (O Saviñao), CP 27543, Spain. Electronic address: a.goyanes@fabrx.co.uk., Couce ML; Servicio de Neonatología, Unidad de Diagnóstico y Tratamiento de Enfermedades Metabólicas Congénitas, Health Research Institute of Santiago de Compostela (IDIS), Hospital Clínico Universitario de Santiago de Compostela, Universidad de Santiago de Compostela, IDIS, RICORS, CIBERER, MetabERN, Spain. Electronic address: maria.luz.couce.pico@sergas.es.
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2024 May 25; Vol. 657, pp. 124140. Date of Electronic Publication: 2024 Apr 19.
Autor:
Goyanes A; FabRx Ltd., 3 Romney Road, Ashford, Kent TN24 0RW, UK; Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma Group (GI-1645), Universidade de Santiago de Compostela, 15782, Spain. Electronic address: a.goyanes@FabRx.co.uk., Madla CM; UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK., Umerji A; UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK., Duran Piñeiro G; Pharmacy Department, Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Travesía Choupana s/n, Santiago de Compostela 15706, Spain., Giraldez Montero JM; Pharmacy Department, Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Travesía Choupana s/n, Santiago de Compostela 15706, Spain., Lamas Diaz MJ; Pharmacy Department, Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Travesía Choupana s/n, Santiago de Compostela 15706, Spain., Gonzalez Barcia M; Pharmacy Department, Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Travesía Choupana s/n, Santiago de Compostela 15706, Spain., Taherali F; UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK., Sánchez-Pintos P; Servicio de Neonatología, Unidad de Diagnóstico y Tratamiento de Enfermedades Metabólicas Congénitas, Hospital Clínico Universitario de Santiago de Compostela, Universidad de Santiago de Compostela, IDIS, CIBERER, MetabERN, Spain., Couce ML; Servicio de Neonatología, Unidad de Diagnóstico y Tratamiento de Enfermedades Metabólicas Congénitas, Hospital Clínico Universitario de Santiago de Compostela, Universidad de Santiago de Compostela, IDIS, CIBERER, MetabERN, Spain., Gaisford S; FabRx Ltd., 3 Romney Road, Ashford, Kent TN24 0RW, UK; UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK., Basit AW; FabRx Ltd., 3 Romney Road, Ashford, Kent TN24 0RW, UK; UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK. Electronic address: a.basit@ucl.ac.uk.
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2019 Aug 15; Vol. 567, pp. 118497. Date of Electronic Publication: 2019 Jul 04.